English
Pусский
Français
Deutsch
العربية
Português
Español
简体中文

News Detail
Home / News / Exhibition / Goldsite Diagnostics Shines at WHX Labs Bangkok 2026: Advancing Accurate Diagnostics Across Southeast Asia

Goldsite Diagnostics Shines at WHX Labs Bangkok 2026: Advancing Accurate Diagnostics Across Southeast Asia

Publish Time: 2026-07-10     Origin: Site

Goldsite Diagnostics Shines at WHX Labs Bangkok 2026: Advancing Accurate Diagnostics Across Southeast Asia

2026 WHX Labs Bangkok

WHX Labs Bangkok — one of the most influential diagnostics and laboratory trade shows in Southeast Asia. Once again, the Goldsite team is here, proudly showcasing our comprehensive portfolio of innovative IVD solutions designed to deliver accurate, reliable, and accessible diagnostics to laboratories across the region. Goldsite Diagnostics Inc. successfully concluded its participation in WHX Labs Bangkok 2026, held from July 8 to 10 at the Queen Sirikit National Convention Center (QSNCC). As a leading innovator in in-vitro diagnostics (IVD), Goldsite showcased its commitment to delivering high-quality, evidence-based laboratory solutions tailored to the evolving healthcare needs of the region.

Booth Highlights 

Our booth (M06) served as a dynamic hub of innovation and collaboration throughout the three-day event. It attracted a significant number of visitors from across Southeast Asia and beyond, including professionals from Thailand, Vietnam, Indonesia, Malaysia, Nepal, Bangladesh, India, and other countries. The engaging layout, live product demonstrations, and expert-led presentations drew keen interest from laboratory directors, clinicians, distributors, and healthcare decision-makers.

The Goldsite team engaged in numerous in-depth discussions, addressing specific clinical challenges and demonstrating the practical benefits of our IVD portfolio. These productive interactions resulted in multiple preliminary cooperation intentions, establishing a robust foundation for long-term business partnerships and accelerated market penetration in the region.

Strongest Visitor Interest: GSH-60 and GSH-50 HPLC HbA1c Analyzers

Among the showcased solutions, the GSH-60 Triple-Mode HPLC HbA1c Analyzer and the newly launched GSH-50 Automatic HPLC HbA1c Analyzer stood out as major highlights, generating substantial visitor engagement and inquiries.

Both systems employ the gold-standard High-Performance Liquid Chromatography (HPLC) methodology, utilizing isoelectric differences to directly separate and quantify HbA1c with exceptional precision (r⊃2; ≥ 0.99) and NGSP/IFCC certification alignment. They support three specialized modes—Normal, Variant, and Thalassemia—while requiring only a minimal 3 µL sample volume, making them highly efficient for routine and complex testing alike.

These solutions address critical regional needs. Southeast Asia faces a high prevalence of thalassemia, which can lead to inaccurate glycemic assessments. The specialized modes in both analyzers provide precise, interference-resistant results, enhancing diagnostic confidence. Concurrently, diabetes has emerged as a major global public health challenge, with the International Diabetes Federation highlighting its rising burden in Asia. Accurate HbA1c testing is essential for effective monitoring and complication prevention, aligning perfectly with Goldsite’s humankind-caring mission to make reliable diagnostics accessible to all.

Positive Outlook

The enthusiastic response at WHX Labs Bangkok reinforces Goldsite’s strategic focus on Southeast Asia. We are committed to accelerating commercialization through enhanced local partnerships, targeted training programs, and responsive technical support. Our goal is to ensure seamless integration of these HPLC systems into diverse laboratory settings, ultimately contributing to improved patient outcomes across the region.

This momentum builds upon existing successes. Goldsite instruments are already installed and performing reliably in laboratories throughout Thailand, Vietnam, Indonesia, and Malaysia, where they have demonstrated strong clinical value through high uptime, excellent correlation with reference methods, and operational efficiency. These real-world implementations validate the robustness of our technologies and the growing trust from healthcare providers.

Sincere Appreciation and Looking Ahead

We extend our heartfelt gratitude to every customer, partner, distributor, and industry professional who visited our booth during the exhibition. Your valuable insights, engaging discussions, and shared vision for advancing diagnostics inspire us to continue innovating with scientific rigor and a deep commitment to human well-being.

We look forward to strengthening these connections and meeting you again at next year’s WHX Labs. Together, let us pave the way for more accurate, accessible diagnostics throughout Southeast Asia and beyond.

Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap